2012-December-20 |
CRO Appointed for Hepatitis C Trial (in PDF) |
2012-December-4 |
Cross Licenses with uniQure for Huntington's and Hep B (in PDF) |
2012-December-3 |
Significant Gene Silencing Demonstrated in Benitec's Muscular Dystrophy Program (in PDF) |
2012-November-20 |
Initiating Research Coverage (in PDF) |
2012-November-16 |
Chairmans Address AGM 2012 (in PDF) |
2012-November-13 |
Lung Cancer Program Gene Silencing (in PDF) |
2012-October-30 |
Tacere Acquisition Completed (in PDF) |
2012-October-22 |
Hepatitis C Patent Allowed in China (in PDF) |
2012-October-11 |
Tacere Acquisition in Phase I/II Hepatitis C Program (in PDF) |
2012-October-8 |
Hepatitis C Patent Granted in China (in PDF) |
2012-October-3 |
Gene Therapy to Control Intractable Pain in Cancer Patients: A New Paradigm? - A Presentation at 6th Annual Pain Therapeutics Summit (in PDF) |
2012-October-2 |
Pain Summit & Investor Conference (in PDF) |
2012-September-25 |
Pathways to Revenue (in PDF) |
2012-August-29 |
Preliminary Final Report (in PDF) |
2012-August-13 |
Stanford University Research Agreement (in PDF) |
2012-July-30 |
Efficacy in Transplant Rejection (in PDF) |
2012-July-23 |
Positive European Regulator Decision (in PDF) |
2012-July-18 |
Alnylam Positive Clinical Results (in PDF) |
2012-July-10 |
Genable License Agreement (in PDF) |
2012-June-28 |
Hep C Scientific Paper (in PDF) |
2012-June-25 |
Withdrawal of Patent Revocation (in PDF) |
2012-June-19 |
Therapeutic Program Update (in PDF) |
2012-June-18 |
Executive Appointment (in PDF) |
2012-May-31 |
New CSIRO Patents (in PDF) |
2012-March-5 |
Calimmune License Deal (in PDF) |
2012-February-29 |
Interim Report for the Half Year Ended December 31, 2011 (in PDF) |
2012-February-7 |
Pre-Clinical Stem Cell Therapy Collaboration (in PDF) |
2012-January-10 |
Cancer Vaccine Clinical Study Results (in PDF) |
2012-January-9 |
Hepatitis C Pre Clinical Results (in PDF) |
2015 |
2015 Press Releases |
2014 |
2014 Press Releases |
2013 |
2013 Press Releases |
2011 |
2011 Press Releases |